Cardlytics Inc (NASDAQ:CDLX) Director Mark A. Johnson sold 100,000 shares of the company’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $32.30, for a total transaction of $3,230,000.00.
Shares of NASDAQ CDLX opened at $34.10 on Thursday. The firm has a market cap of $808.56 million, a PE ratio of -15.93 and a beta of 1.53. The company has a current ratio of 2.01, a quick ratio of 2.01 and a debt-to-equity ratio of 0.79. Cardlytics Inc has a 1-year low of $9.80 and a 1-year high of $39.62. The company has a fifty day moving average price of $33.69 and a 200 day moving average price of $24.16.
Cardlytics (NASDAQ:CDLX) last announced its earnings results on Thursday, August 8th. The company reported ($0.12) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.35) by $0.23. The firm had revenue of $48.73 million during the quarter, compared to analyst estimates of $43.77 million. Cardlytics had a negative net margin of 19.60% and a negative return on equity of 66.01%. The company’s revenue for the quarter was up 37.0% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.21) EPS. Equities research analysts forecast that Cardlytics Inc will post -1.08 EPS for the current year.
A number of analysts recently commented on CDLX shares. ValuEngine cut shares of Cardlytics from a “buy” rating to a “hold” rating in a research report on Wednesday, September 4th. William Blair initiated coverage on shares of Cardlytics in a research note on Monday, July 1st. They issued an “outperform” rating for the company. Raymond James upped their target price on shares of Cardlytics from $24.00 to $40.00 and gave the stock an “outperform” rating in a research note on Friday, August 9th. Zacks Investment Research lowered shares of Cardlytics from a “buy” rating to a “hold” rating in a research note on Tuesday, July 23rd. Finally, SunTrust Banks upped their target price on shares of Cardlytics from $25.00 to $35.00 and gave the stock a “buy” rating in a research note on Friday, August 9th. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $33.29.
Cardlytics Company Profile
Cardlytics, Inc operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.
Featured Article: What is a death cross?
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.